{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/how-assumptions-protocol-design-are-root-trial-failure-avoiding-unicorns-clinical-trial#webpage",
"url": "https://www.fortrea.com/insights/how-assumptions-protocol-design-are-root-trial-failure-avoiding-unicorns-clinical-trial",
"name": "How assumptions in protocol design are a root of trial failure: Avoiding “unicorns” in clinical trial protocol design",
"description": "This Fortrea info sheet highlights clinical trial protocol design strategies focused on avoiding “unicorns” by reducing unrealistic study assumptions and improving trial execution across complex clinical development programs. The publication discusses protocol optimization approaches related to trial complexity, patient burden reduction, endpoint selection, operational feasibility, and study execution planning within modern protocol development activities. The publication also highlights challenges associated with overly complex study designs, unrealistic protocol expectations, recruitment barriers, protocol amendments, and operational inefficiencies that can negatively affect clinical trial timelines and study performance. Fortrea supports sponsors through structured protocol development strategies designed to strengthen protocol quality, improve operational alignment, and support more effective clinical trial execution across global studies. By integrating patient-centered planning with practical protocol design approaches, Fortrea supports stronger study performance and more efficient clinical development outcomes"
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "How assumptions in protocol design are a root of trial failure: Avoiding “unicorns” in clinical trial protocol design",
"item": "https://www.fortrea.com/insights/how-assumptions-protocol-design-are-root-trial-failure-avoiding-unicorns-clinical-trial"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/how-assumptions-protocol-design-are-root-trial-failure-avoiding-unicorns-clinical-trial#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/how-assumptions-protocol-design-are-root-trial-failure-avoiding-unicorns-clinical-trial#webpage"
},
"headline": "Avoiding “Unicorns” in Clinical Trial Protocol Design to Improve Study Execution | Fortrea Info Sheet",
"description": "This Fortrea info sheet highlights clinical trial protocol design strategies focused on avoiding “unicorns” by reducing unrealistic study assumptions and improving trial execution across complex clinical development programs. The publication discusses protocol optimization approaches related to trial complexity, patient burden reduction, endpoint selection, operational feasibility, and study execution planning within modern protocol development activities. The publication also highlights challenges associated with overly complex study designs, unrealistic protocol expectations, recruitment barriers, protocol amendments, and operational inefficiencies that can negatively affect clinical trial timelines and study performance. Fortrea supports sponsors through structured protocol development strategies designed to strengthen protocol quality, improve operational alignment, and support more effective clinical trial execution across global studies. By integrating patient-centered planning with practical protocol design approaches, Fortrea supports stronger study performance and more efficient clinical development outcomes",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/avoiding-unicorns-in-clinical-trial-protocol-design_1.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-05-10",
"dateModified": "2025-05-10",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-05/avoiding-unicorns-in-clinical-trial-protocol-design.pdf",
"encodingFormat": "application/pdf"
}
}
]
}